Literature DB >> 36050597

Molecular Characterization of Probiotics and Their Influence on Children with Autism Spectrum Disorder.

Nagwa A Meguid1,2, Youssef Imam A Mawgoud3, Geir Bjørklund4, Nayra Shakar Mehanne5, Mona Anwar1,6, Baher Abd El-Khalik Effat5, Salvatore Chirumbolo7,8, Manar Magdy Abd Elrahman5.   

Abstract

Children with autism spectrum disorder (ASD) are usually unable to express abdominal discomfort properly, and thus gastrointestinal symptoms (GIS) are sometimes shadowed by aggression, which is sometimes misunderstood as a behavioral characteristic of ASD. Several studies have reported interesting correlations between the severity of behavioral and gastrointestinal symptoms in ASD children. The present study aimed to investigate the potential effects of probiotics as an adjuvant therapy to modulate the clinical status of ASD children. This study included 40 children with ASD aged 2-5 years. The feeding product was prepared from whey powder (without casein) and some minced cooked yellow vegetables in adequate ratios fortified with the studied probiotic strains (Bifidobacterium spp. and Lactobacillus spp.). Bifidobacterium strains were assessed from stool samples of children with ASD. Bifidobacterium strains were analyzed in the stools of ASD children. Recruited ASD patients received 10 g of the nutritional supplement once a day for 3 months. Childhood Autism Rating Scale (CARS) and Autism Diagnostic Interview-Revised (ADIR) were reevaluated clinically. Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III Version was used for all children with ASD before and after. There is a significant increase in the colony counts of both Bifidobacterium spp. and Lactobacillus spp., which present in the stool of ASD children after probiotic supplementation for 3 months. It was highly significant in the case of Bifidobacterium spp. (p value 0.000) and a significant increase in Lactobacillus spp. (p value 0.015). The present study showed reduced anxiety and observation of deep sleep for children with ASD (80%) after taking the supplementation. This indicates that probiotics may have a potential effect in reducing symptoms and severity of ASD and in correcting dysbiosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autism; Bifidobacterium spp; Lactobacillus spp; Probiotics

Mesh:

Substances:

Year:  2022        PMID: 36050597     DOI: 10.1007/s12035-022-02963-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  16 in total

1.  The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy.

Authors:  J R Cole; B Chai; T L Marsh; R J Farris; Q Wang; S A Kulam; S Chandra; D M McGarrell; T M Schmidt; G M Garrity; J M Tiedje
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 2.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

3.  Impact of Clostridium Bacteria in Children with Autism Spectrum Disorder and Their Anthropometric Measurements.

Authors:  Wafaa A Kandeel; Nagwa A Meguid; Geir Bjørklund; Ehab M Eid; Maisa Farid; Sanaa K Mohamed; Khaled E Wakeel; Salvatore Chirumbolo; Amal Elsaeid; Doaa Y Hammad
Journal:  J Mol Neurosci       Date:  2020-03-04       Impact factor: 3.444

4.  Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis.

Authors:  Barbara O McElhanon; Courtney McCracken; Saul Karpen; William G Sharp
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

5.  Gastrointestinal microflora studies in late-onset autism.

Authors:  Sydney M Finegold; Denise Molitoris; Yuli Song; Chengxu Liu; Marja-Liisa Vaisanen; Ellen Bolte; Maureen McTeague; Richard Sandler; Hannah Wexler; Elizabeth M Marlowe; Matthew D Collins; Paul A Lawson; Paula Summanen; Mehmet Baysallar; Thomas J Tomzynski; Erik Read; Eric Johnson; Rial Rolfe; Palwasha Nasir; Haroun Shah; David A Haake; Patricia Manning; Ajay Kaul
Journal:  Clin Infect Dis       Date:  2002-09-01       Impact factor: 9.079

Review 6.  Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders.

Authors:  Narek Israelyan; Kara Gross Margolis
Journal:  Pharmacol Res       Date:  2018-03-31       Impact factor: 7.658

7.  Design and evaluation of Bacteroides DNA probes for the specific detection of human fecal pollution.

Authors:  C A Kreader
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

Review 8.  The Microbiota-Gut-Brain Axis.

Authors:  John F Cryan; Kenneth J O'Riordan; Caitlin S M Cowan; Kiran V Sandhu; Thomaz F S Bastiaanssen; Marcus Boehme; Martin G Codagnone; Sofia Cussotto; Christine Fulling; Anna V Golubeva; Katherine E Guzzetta; Minal Jaggar; Caitriona M Long-Smith; Joshua M Lyte; Jason A Martin; Alicia Molinero-Perez; Gerard Moloney; Emanuela Morelli; Enrique Morillas; Rory O'Connor; Joana S Cruz-Pereira; Veronica L Peterson; Kieran Rea; Nathaniel L Ritz; Eoin Sherwin; Simon Spichak; Emily M Teichman; Marcel van de Wouw; Ana Paula Ventura-Silva; Shauna E Wallace-Fitzsimons; Niall Hyland; Gerard Clarke; Timothy G Dinan
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

9.  Database resources of the National Center for Biotechnology Information.

Authors:  David L Wheeler; Tanya Barrett; Dennis A Benson; Stephen H Bryant; Kathi Canese; Vyacheslav Chetvernin; Deanna M Church; Michael DiCuccio; Ron Edgar; Scott Federhen; Lewis Y Geer; Wolfgang Helmberg; Yuri Kapustin; David L Kenton; Oleg Khovayko; David J Lipman; Thomas L Madden; Donna R Maglott; James Ostell; Kim D Pruitt; Gregory D Schuler; Lynn M Schriml; Edwin Sequeira; Stephen T Sherry; Karl Sirotkin; Alexandre Souvorov; Grigory Starchenko; Tugba O Suzek; Roman Tatusov; Tatiana A Tatusova; Lukas Wagner; Eugene Yaschenko
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  Emerging evidence for gene mutations driving both brain and gut dysfunction in autism spectrum disorder.

Authors:  Beate Niesler; Gudrun A Rappold
Journal:  Mol Psychiatry       Date:  2020-05-27       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.